CovalX will be attending The 18th Annual Discovery on Target (DOT) – Virtual, the industry’s preeminent event on novel drug targets and technologies. DOT provides an overview of current and emerging technologies and research as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.
This year program also includes the new topics on proteomics, small G proteins, disease modeling, preclinical oncology models and tools, CNS, gene and cell therapy, and biomarkers, plus lead and candidate selection for therapeutic proteins and modality selection for next-generation biotherapeutics.
Due to the ongoing coronavirus pandemic, DOT is offering this entire event virtually including the scientific collaborations among industry and academic researchers. Members of our scientific team, Ryan Wenzel will be there to answer any of your questions regarding our services.